effect overlay
activetrials
Movement Disorders
Movement Disorders
Parkinson's ISC-hpNSC

A single arm, open-label, phase I study to evaluate the safety and tolerability of ISC-hpNSC injected into the striatum and substantia nigra of patients with Parkinson's disease
 

HREC: 2015.145
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Commercial
Movement Disorders
Movement Disorders
Parkinson's fMRI Study

Dyskinesia and pain may share common pathophysiological mechanisms in Parkinson's disease: A fMRI study
 

HREC: 2010.289
Principal Investigator: Dr Andrew Evans
Coordinator contact: Dr Simon Sung
Funding: Non-Commercial